Valuation: Bayer AG

Market Cap 49.69B 55.48B 45.71B 41.42B 77.41B 5,268B 78.86B 545B 219B 2,771B 208B 204B 8,739B P/E 2026 *
22.4x
P/E 2027 * 16.2x
Enterprise Value 79.42B 88.68B 73.05B 66.19B 124B 8,420B 126B 871B 350B 4,429B 333B 326B 13,968B EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.62x
Free-Float
99.99%
Yield 2026 *
0.28%
Yield 2027 * 1.1%
1 day+5.46%
1 week+15.01%
Current month+5.48%
1 month+5.48%
3 months+4.42%
6 months+32.93%
Current year+36.67%
1 week 44.51
Extreme 44.51
50.66
1 month 42.56
Extreme 42.56
50.66
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
18/3/26 Buy

Director

1,900 0.0002%
18/3/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/3/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+5.46%+15.01%+88.24%+24.34% 55.48B
+3.19%+11.31%+67.86%+150.58% 1,263B
-0.73%+3.56%+44.51%+85.81% 658B
+1.41%+3.24%+29.22%+107.83% 521B
+0.42%+3.20%+54.15%+67.18% 391B
+2.18%+2.93%+73.30%+45.62% 369B
+1.12%+4.52%+35.30%+58.08% 307B
+6.96%+8.86%+11.27%+36.62% 290B
+1.15%+6.09%+59.59%+77.06% 252B
+3.06%+9.38%+44.11%+119.47% 212B
Average +2.10%+6.81%+50.75%+77.26% 431.74B
Weighted average by Cap. +1.25%+6.71%+51.36%+97.36%

Financials

2026 *2027 *
Net sales 45.87B 51.22B 42.19B 38.23B 71.46B 4,863B 72.8B 503B 202B 2,558B 192B 188B 8,067B 47.05B 52.54B 43.28B 39.21B 73.3B 4,988B 74.67B 516B 207B 2,624B 197B 193B 8,275B
Net income 2.3B 2.56B 2.11B 1.91B 3.58B 244B 3.65B 25.2B 10.11B 128B 9.62B 9.42B 404B 2.98B 3.32B 2.74B 2.48B 4.64B 316B 4.72B 32.65B 13.11B 166B 12.47B 12.21B 524B
Net Debt 29.73B 33.2B 27.35B 24.78B 46.32B 3,152B 47.18B 326B 131B 1,658B 125B 122B 5,229B 26.39B 29.47B 24.28B 22B 41.12B 2,798B 41.88B 289B 116B 1,472B 111B 108B 4,642B
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
30/10/26 EUR 50.58 +5.46% 5,106,907
29/10/26 EUR 47.96 +4.19% 2,660,395
28/10/26 EUR 46.03 -0.26% 1,786,980
27/10/26 EUR 46.15 +1.29% 1,801,210
26/10/26 EUR 45.56 +3.59% 1,964,992
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
50.58EUR
Average target price
58.33EUR
Spread / Average Target
+15.33%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bayer AG
  1. Stock Market
  2. Stocks
  3. BAYN Stock